My69z,
From your post, 2 stroke patients got better,
My69z,
From your post, 2 stroke patients got better, reported somewhere on 10/26/2020.
On the other hands:
--Nearly 4.5 years later, not a peep about advancing this ball?
--Vax: The current list of recommended vaccines is long (medical-industrial complex?), much longer than when we were kids. What's a birthing person to do?
--Short GSK: Would Citadel push all those chips into the pot just to make others sell after a share price run up? Do they also have rabid leaders steering their ship? Is there a waiting list to receive one of their Teslas they'll be giving away in protest?
--Cake vs Pie: Wow, that seems so long ago, all in good fun. Not required knowledge for a newcomer. Current situation (from Ken): Amazing molecule with much better management who will continue to lead us in the climb out from our 10 cent bottom. Buy while we're still on sale.
--Friday Happy Hour: I wouldn't want to do that. Other sites available for that, as mentioned. There's too much to get done together and too much we can learn from each other in a civil fashion. Should we risk productive relationships by lining up once per week to throw snowballs, ice balls, dirt clods at the other side? You could take someone's eye out (don't see eye enucleation on the list). Repeating, many other reasons on The List to make a Buy or buy more decision.
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding the Challenges of Early Career Professionals As the new generation of professionals prepares to step into the workforce, they often face a variety of challenges. Recent insights from professionals reveal common hurdles that individuals might encounter early in their careers. Understanding these challenges is the first step toward successfully navigating...
Continue Reading
Pharming Sets a New Course with Strategic Acquisition Strengthening the Pipeline with a First-in-Disease Asset Pharming Group N.V. has recently made headlines with its ambitious public cash offer for Abliva AB. This strategic acquisition, valued at approximately US$66.1 million, aims to advance Pharming's late-stage pipeline significantly. At the heart of this acquisition...
Continue Reading
Golden Sun Health Technology Group Limited Ventures into Cultural Tourism Golden Sun Health Technology Group Limited, previously known as Golden Sun Education Group Limited (NASDAQ: GSUN), has made a notable step forward by launching a joint venture aimed at tapping into the cultural tourism market. Through its wholly-owned subsidiary, Shanghai Golden Sun Gongyu Education...
Continue Reading
BlackRock Municipal Income Fund Transition Announcement BlackRock Municipal Income Fund, Inc. (NYSE: MUI, referred to as the “Fund”) is set to undergo an exciting transition. The Fund will change from an exchange-listed closed-end fund to an unlisted continuously-offered closed-end fund, which will conduct quarterly repurchases of its shares. This new venture will be...
Continue Reading
Understanding the CrowdStrike Holdings Class Action Attention shareholders of CrowdStrike Holdings, Inc. (NASDAQ: CRWD): If you acquired shares during the specified class period, it’s important to understand your rights regarding an ongoing class action. Recent developments have raised concerns about the company's operations, particularly in relation to its flagship...
Continue Reading